カテゴリー： QYResearch, 世界

世界の次世代がん診断デバイス市場 2019年

【英語タイトル】Global Next Generation Cancer Diagnostic Devices Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X11973）・商品コード：DATA909X11973
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：116
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、次世代がん診断デバイスの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、次世代シーケンス、qPCR＆多重化、ラボオンチップ（LOAC）＆逆転写酵素-PCR（RT-PCR）、タンパク質マイクロアレイ、DNAマイクロアレイに、用途別には、バイオマーカー開発、CTC分析、プロテオーム分析、エピジェネティック分析、遺伝子分析にセグメント区分し、次世代がん診断デバイスの世界市場を分析しました。


・エグゼクティブ・サマリー
・次世代がん診断デバイスの世界市場概要
・次世代がん診断デバイスの製造コスト構成分析
・次世代がん診断デバイスの開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・次世代がん診断デバイスの地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・次世代がん診断デバイスのセグメント分析（種類別）
（次世代シーケンス、qPCR＆多重化、ラボオンチップ（LOAC）＆逆転写酵素-PCR（RT-PCR）、タンパク質マイクロアレイ、DNAマイクロアレイ）
・次世代がん診断デバイスのセグメント分析（用途別）
（バイオマーカー開発、CTC分析、プロテオーム分析、エピジェネティック分析、遺伝子分析）
・次世代がん診断デバイスの主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Roche Holding Ltd.（Switzerland)、Abbott Laboratories(US)、Siemens Healthcare(Germany)、Agilent Technologies Inc(Germany)、Illumina Inc.(US)、Becton Dickinson and Co.(US)、QIAGEN N.V.(Germany)、Affymetrix Inc.(US)、Johnson & Johnson(US)、Thermo Fisher Scientific Inc.(US)、GE Healthcare(England)、Life Technologies Corp.(US)、Luminex Corp.(US)、Cepheid Inc.(US)、Allegro Diagnostics Corp.(Brazil)、）
・次世代がん診断デバイスの市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Next Generation Cancer Diagnostic Devices market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Next Generation Cancer Diagnostic Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Next Generation Cancer Diagnostic Devices market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Next Generation Cancer Diagnostic Devices in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Next Generation Cancer Diagnostic Devices manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Roche Holding Ltd.（Switzerland)
Abbott Laboratories(US)
Siemens Healthcare(Germany)
Agilent Technologies Inc(Germany)
Illumina Inc.(US)
Becton Dickinson and Co.(US)
QIAGEN N.V.(Germany)
Affymetrix Inc.(US)
Johnson & Johnson(US)
Thermo Fisher Scientific Inc.(US)
GE Healthcare(England)
Life Technologies Corp.(US)
Luminex Corp.(US)
Cepheid Inc.(US)
Allegro Diagnostics Corp.(Brazil)

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Next Generation Sequencing
qPCR & Multiplexing
Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
Protein Microarrays
DNA Microarrays

Segment by Application
Biomarker Development
CTC Analysis
Proteomic Analysis
Epigenetic Analysis
Genetic Analysis

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Next Generation Cancer Diagnostic Devices
1.1 Definition of Next Generation Cancer Diagnostic Devices
1.2 Next Generation Cancer Diagnostic Devices Segment by Type
1.2.1 Global Next Generation Cancer Diagnostic Devices Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Next Generation Sequencing
1.2.3 qPCR & Multiplexing
1.2.4 Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
1.2.5 Protein Microarrays
1.2.6 DNA Microarrays
1.3 Next Generation Cancer Diagnostic Devices Segment by Applications
1.3.1 Global Next Generation Cancer Diagnostic Devices Consumption Comparison by Applications (2014-2025)
1.3.2 Biomarker Development
1.3.3 CTC Analysis
1.3.4 Proteomic Analysis
1.3.5 Epigenetic Analysis
1.3.6 Genetic Analysis
1.4 Global Next Generation Cancer Diagnostic Devices Overall Market
1.4.1 Global Next Generation Cancer Diagnostic Devices Revenue (2014-2025)
1.4.2 Global Next Generation Cancer Diagnostic Devices Production (2014-2025)
1.4.3 North America Next Generation Cancer Diagnostic Devices Status and Prospect (2014-2025)
1.4.4 Europe Next Generation Cancer Diagnostic Devices Status and Prospect (2014-2025)
1.4.5 China Next Generation Cancer Diagnostic Devices Status and Prospect (2014-2025)
1.4.6 Japan Next Generation Cancer Diagnostic Devices Status and Prospect (2014-2025)
1.4.7 Southeast Asia Next Generation Cancer Diagnostic Devices Status and Prospect (2014-2025)
1.4.8 India Next Generation Cancer Diagnostic Devices Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Next Generation Cancer Diagnostic Devices
2.3 Manufacturing Process Analysis of Next Generation Cancer Diagnostic Devices
2.4 Industry Chain Structure of Next Generation Cancer Diagnostic Devices

3 Development and Manufacturing Plants Analysis of Next Generation Cancer Diagnostic Devices
3.1 Capacity and Commercial Production Date
3.2 Global Next Generation Cancer Diagnostic Devices Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Next Generation Cancer Diagnostic Devices
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Next Generation Cancer Diagnostic Devices Production and Capacity Analysis
4.2 Next Generation Cancer Diagnostic Devices Revenue Analysis
4.3 Next Generation Cancer Diagnostic Devices Price Analysis
4.4 Market Concentration Degree

5 Next Generation Cancer Diagnostic Devices Regional Market Analysis
5.1 Next Generation Cancer Diagnostic Devices Production by Regions
5.1.1 Global Next Generation Cancer Diagnostic Devices Production by Regions
5.1.2 Global Next Generation Cancer Diagnostic Devices Revenue by Regions
5.2 Next Generation Cancer Diagnostic Devices Consumption by Regions
5.3 North America Next Generation Cancer Diagnostic Devices Market Analysis
5.3.1 North America Next Generation Cancer Diagnostic Devices Production
5.3.2 North America Next Generation Cancer Diagnostic Devices Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Next Generation Cancer Diagnostic Devices Import and Export
5.4 Europe Next Generation Cancer Diagnostic Devices Market Analysis
5.4.1 Europe Next Generation Cancer Diagnostic Devices Production
5.4.2 Europe Next Generation Cancer Diagnostic Devices Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Next Generation Cancer Diagnostic Devices Import and Export
5.5 China Next Generation Cancer Diagnostic Devices Market Analysis
5.5.1 China Next Generation Cancer Diagnostic Devices Production
5.5.2 China Next Generation Cancer Diagnostic Devices Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Next Generation Cancer Diagnostic Devices Import and Export
5.6 Japan Next Generation Cancer Diagnostic Devices Market Analysis
5.6.1 Japan Next Generation Cancer Diagnostic Devices Production
5.6.2 Japan Next Generation Cancer Diagnostic Devices Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Next Generation Cancer Diagnostic Devices Import and Export
5.7 Southeast Asia Next Generation Cancer Diagnostic Devices Market Analysis
5.7.1 Southeast Asia Next Generation Cancer Diagnostic Devices Production
5.7.2 Southeast Asia Next Generation Cancer Diagnostic Devices Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Next Generation Cancer Diagnostic Devices Import and Export
5.8 India Next Generation Cancer Diagnostic Devices Market Analysis
5.8.1 India Next Generation Cancer Diagnostic Devices Production
5.8.2 India Next Generation Cancer Diagnostic Devices Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Next Generation Cancer Diagnostic Devices Import and Export

6 Next Generation Cancer Diagnostic Devices Segment Market Analysis (by Type)
6.1 Global Next Generation Cancer Diagnostic Devices Production by Type
6.2 Global Next Generation Cancer Diagnostic Devices Revenue by Type
6.3 Next Generation Cancer Diagnostic Devices Price by Type

7 Next Generation Cancer Diagnostic Devices Segment Market Analysis (by Application)
7.1 Global Next Generation Cancer Diagnostic Devices Consumption by Application
7.2 Global Next Generation Cancer Diagnostic Devices Consumption Market Share by Application (2014-2019)

8 Next Generation Cancer Diagnostic Devices Major Manufacturers Analysis
8.1 Roche Holding Ltd.（Switzerland)
8.1.1 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
8.1.2 Roche Holding Ltd.（Switzerland) Product Introduction, Application and Specification
8.1.3 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Abbott Laboratories(US)
8.2.1 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
8.2.2 Abbott Laboratories(US) Product Introduction, Application and Specification
8.2.3 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Siemens Healthcare(Germany)
8.3.1 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
8.3.2 Siemens Healthcare(Germany) Product Introduction, Application and Specification
8.3.3 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Agilent Technologies Inc(Germany)
8.4.1 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
8.4.2 Agilent Technologies Inc(Germany) Product Introduction, Application and Specification
8.4.3 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Illumina Inc.(US)
8.5.1 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
8.5.2 Illumina Inc.(US) Product Introduction, Application and Specification
8.5.3 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Becton Dickinson and Co.(US)
8.6.1 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
8.6.2 Becton Dickinson and Co.(US) Product Introduction, Application and Specification
8.6.3 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 QIAGEN N.V.(Germany)
8.7.1 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
8.7.2 QIAGEN N.V.(Germany) Product Introduction, Application and Specification
8.7.3 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Affymetrix Inc.(US)
8.8.1 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
8.8.2 Affymetrix Inc.(US) Product Introduction, Application and Specification
8.8.3 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Johnson & Johnson(US)
8.9.1 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
8.9.2 Johnson & Johnson(US) Product Introduction, Application and Specification
8.9.3 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Thermo Fisher Scientific Inc.(US)
8.10.1 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
8.10.2 Thermo Fisher Scientific Inc.(US) Product Introduction, Application and Specification
8.10.3 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 GE Healthcare(England)
8.12 Life Technologies Corp.(US)
8.13 Luminex Corp.(US)
8.14 Cepheid Inc.(US)
8.15 Allegro Diagnostics Corp.(Brazil)

9 Development Trend of Analysis of Next Generation Cancer Diagnostic Devices Market
9.1 Global Next Generation Cancer Diagnostic Devices Market Trend Analysis
9.1.1 Global Next Generation Cancer Diagnostic Devices Market Size (Volume and Value) Forecast 2019-2025
9.2 Next Generation Cancer Diagnostic Devices Regional Market Trend
9.2.1 North America Next Generation Cancer Diagnostic Devices Forecast 2019-2025
9.2.2 Europe Next Generation Cancer Diagnostic Devices Forecast 2019-2025
9.2.3 China Next Generation Cancer Diagnostic Devices Forecast 2019-2025
9.2.4 Japan Next Generation Cancer Diagnostic Devices Forecast 2019-2025
9.2.5 Southeast Asia Next Generation Cancer Diagnostic Devices Forecast 2019-2025
9.2.6 India Next Generation Cancer Diagnostic Devices Forecast 2019-2025
9.3 Next Generation Cancer Diagnostic Devices Market Trend (Product Type)
9.4 Next Generation Cancer Diagnostic Devices Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Next Generation Cancer Diagnostic Devices Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Next Generation Cancer Diagnostic Devices
Table Global Next Generation Cancer Diagnostic Devices Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Next Generation Cancer Diagnostic Devices Production Market Share by Types in 2018
Figure Next Generation Sequencing Product Picture
Figure qPCR & Multiplexing Product Picture
Figure Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR) Product Picture
Figure Protein Microarrays Product Picture
Figure DNA Microarrays Product Picture
Table Global Next Generation Cancer Diagnostic Devices Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Next Generation Cancer Diagnostic Devices Consumption Market Share by Applications in 2018
Figure Biomarker Development
Figure CTC Analysis
Figure Proteomic Analysis
Figure Epigenetic Analysis
Figure Genetic Analysis
Figure Global Next Generation Cancer Diagnostic Devices Revenue (Million USD) (2014-2025)
Figure Global Next Generation Cancer Diagnostic Devices Production (K Pcs) (2014-2025)
Figure North America Next Generation Cancer Diagnostic Devices Market Size (Million USD) (2014-2025)
Figure Europe Next Generation Cancer Diagnostic Devices Market Size (Million USD) (2014-2025)
Figure China Next Generation Cancer Diagnostic Devices Market Size (Million USD) (2014-2025)
Figure Japan Next Generation Cancer Diagnostic Devices Market Size (Million USD) (2014-2025)
Figure Southeast Asia Next Generation Cancer Diagnostic Devices Market Size (Million USD) (2014-2025)
Figure India Next Generation Cancer Diagnostic Devices Market Size (Million USD) (2014-2025)
Table Next Generation Cancer Diagnostic Devices Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Next Generation Cancer Diagnostic Devices in 2018
Figure Manufacturing Process Analysis of Next Generation Cancer Diagnostic Devices
Figure Industry Chain Structure of Next Generation Cancer Diagnostic Devices
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Next Generation Cancer Diagnostic Devices Manufacturing Plants Distribution
Table Next Generation Cancer Diagnostic Devices Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Next Generation Cancer Diagnostic Devices Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Next Generation Cancer Diagnostic Devices Production (K Pcs) of Major Manufacturers (2014-2019)
Table Next Generation Cancer Diagnostic Devices Production Market Share of Major Manufacturers (2014-2019)
Figure Next Generation Cancer Diagnostic Devices Production Share by Manufacturers in 2018
Table Next Generation Cancer Diagnostic Devices Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Next Generation Cancer Diagnostic Devices Revenue Market Share of Major Manufacturers (2014-2019)
Figure Next Generation Cancer Diagnostic Devices Revenue Share by Manufacturers in 2018
Table Next Generation Cancer Diagnostic Devices Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Next Generation Cancer Diagnostic Devices Production by Regions 2014-2019 (K Pcs)
Table Global Next Generation Cancer Diagnostic Devices Production Market Share by Regions 2014-2019
Figure Global Next Generation Cancer Diagnostic Devices Production Market Share by Regions in 2018
Table Global Next Generation Cancer Diagnostic Devices Revenue by Regions 2014-2019 (Million USD)
Table Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Regions 2014-2019
Figure Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Regions in 2018
Table Global Next Generation Cancer Diagnostic Devices Consumption by Regions 2014-2019 (K Pcs)
Table Global Next Generation Cancer Diagnostic Devices Consumption Market Share by Regions 2014-2019
Figure North America Next Generation Cancer Diagnostic Devices Production Growth Rate 2014-2019 (K Pcs)
Figure North America Next Generation Cancer Diagnostic Devices Revenue Growth Rate 2014-2019 (Million USD)
Table North America Next Generation Cancer Diagnostic Devices Production, Consumption Import and Export (K Pcs)
Figure Europe Next Generation Cancer Diagnostic Devices Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Next Generation Cancer Diagnostic Devices Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Next Generation Cancer Diagnostic Devices Production, Consumption Import and Export (K Pcs)
Figure China Next Generation Cancer Diagnostic Devices Production Growth Rate 2014-2019 (K Pcs)
Figure China Next Generation Cancer Diagnostic Devices Revenue Growth Rate 2014-2019 (Million USD)
Table China Next Generation Cancer Diagnostic Devices Production, Consumption Import and Export (K Pcs)
Figure Japan Next Generation Cancer Diagnostic Devices Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Next Generation Cancer Diagnostic Devices Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Next Generation Cancer Diagnostic Devices Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Next Generation Cancer Diagnostic Devices Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Next Generation Cancer Diagnostic Devices Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Next Generation Cancer Diagnostic Devices Production, Consumption Import and Export (K Pcs)
Figure India Next Generation Cancer Diagnostic Devices Production Growth Rate 2014-2019 (K Pcs)
Figure India Next Generation Cancer Diagnostic Devices Revenue Growth Rate 2014-2019 (Million USD)
Table India Next Generation Cancer Diagnostic Devices Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Next Generation Cancer Diagnostic Devices Market Share by Application (2014-2019)
Figure Global Value (Consumption) Next Generation Cancer Diagnostic Devices Market Share by Application (2014-2019)
Table Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
Table Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
Table Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Production Growth Rate (2014-2019)
Table Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Production Market Share (2014-2019)
Figure Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Revenue Market Share (2014-2019)
Table Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Main Business and Markets Served
Table Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
Table Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
Table Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Production Growth Rate (2014-2019)
Table Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Production Market Share (2014-2019)
Figure Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Revenue Market Share (2014-2019)
Table Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Main Business and Markets Served
Table Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
Table Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
Table Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Production Growth Rate (2014-2019)
Table Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Production Market Share (2014-2019)
Figure Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Revenue Market Share (2014-2019)
Table Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Main Business and Markets Served
Table Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
Table Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
Table Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Production Growth Rate (2014-2019)
Table Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Production Market Share (2014-2019)
Figure Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Revenue Market Share (2014-2019)
Table Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Main Business and Markets Served
Table Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
Table Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
Table Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Production Growth Rate (2014-2019)
Table Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Production Market Share (2014-2019)
Figure Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Revenue Market Share (2014-2019)
Table Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Main Business and Markets Served
Table Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
Table Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
Table Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Production Growth Rate (2014-2019)
Table Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Production Market Share (2014-2019)
Figure Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Revenue Market Share (2014-2019)
Table Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Main Business and Markets Served
Table QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
Table QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
Table QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Production Growth Rate (2014-2019)
Table QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Production Market Share (2014-2019)
Figure QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Revenue Market Share (2014-2019)
Table QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Main Business and Markets Served
Table Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
Table Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
Table Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Production Growth Rate (2014-2019)
Table Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Production Market Share (2014-2019)
Figure Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Revenue Market Share (2014-2019)
Table Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Main Business and Markets Served
Table Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
Table Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
Table Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Production Growth Rate (2014-2019)
Table Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Production Market Share (2014-2019)
Figure Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Revenue Market Share (2014-2019)
Table Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Main Business and Markets Served
Table Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
Table Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
Table Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Production Growth Rate (2014-2019)
Table Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Production Market Share (2014-2019)
Figure Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Revenue Market Share (2014-2019)
Table Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Main Business and Markets Served
Table GE Healthcare(England) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
Table Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
Table Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
Table Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
Table Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Production Sites and Area Served
Figure Global Next Generation Cancer Diagnostic Devices Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Next Generation Cancer Diagnostic Devices Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Next Generation Cancer Diagnostic Devices Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Next Generation Cancer Diagnostic Devices Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Next Generation Cancer Diagnostic Devices Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Next Generation Cancer Diagnostic Devices Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Next Generation Cancer Diagnostic Devices Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Next Generation Cancer Diagnostic Devices Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Next Generation Cancer Diagnostic Devices Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Next Generation Cancer Diagnostic Devices Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Next Generation Cancer Diagnostic Devices Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Next Generation Cancer Diagnostic Devices Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Next Generation Cancer Diagnostic Devices Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Next Generation Cancer Diagnostic Devices Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Next Generation Cancer Diagnostic Devices Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Next Generation Cancer Diagnostic Devices by Type (2019-2025)
Table Global Consumption (K Pcs) of Next Generation Cancer Diagnostic Devices by Application (2019-2025)
Table Next Generation Cancer Diagnostic Devices Distributors List
Table Next Generation Cancer Diagnostic Devices Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Roche Holding Ltd.（Switzerland)、Abbott Laboratories(US)、Siemens Healthcare(Germany)、Agilent Technologies Inc(Germany)、Illumina Inc.(US)、Becton Dickinson and Co.(US)、QIAGEN N.V.(Germany)、Affymetrix Inc.(US)、Johnson & Johnson(US)、Thermo Fisher Scientific Inc.(US)、GE Healthcare(England)、Life Technologies Corp.(US)、Luminex Corp.(US)、Cepheid Inc.(US)、Allegro Diagnostics Corp.(Brazil)、

★調査レポート[世界の次世代がん診断デバイス市場 2019年] (コード：DATA909X11973)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の次世代がん診断デバイス市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 膵臓がん診断装置の世界市場：規模・現状・予測2019-2025
    DATA909X18794 / QYResearch / 2019年11月25日 / ※当調査レポートでは、膵臓がん診断装置の世界市場について調査・分析し、膵臓がん診断装置の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（イメージング、腫瘍バイオマーカー、生検、その他）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の膵臓がん診断装置市場動向 ・主要企業別マーケットシェア ・膵臓がん診断装置の種類別市場規模2014-2019 （イメージング、腫瘍バイオマーカー、生検、その他） ・膵臓がん診断装置の用途別市場規模2014-2019 （病院、クリニック、その他） ・膵臓がん診断装置の北米市場：主要企業・種類別/用途別市場規模 ・膵臓がん診断装置のヨーロッパ市場：主要企業・種類別/用途別市場規模...Imaging tests that create pictures of your internal organs. These tests help your doctors visualize your internal organs, including the pancreas. Techniques used to diagnose pancreatic cancer include ultrasound, computerized tomography (CT) scans, magnetic resonance imaging (MRI) and, sometimes, positron emission tomography (PET) scans.In 2018, the global Pancreatic Cancer Diagnostic Devices market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Pancreatic Cancer Diagnostic Devices status, future forecast, growth opportunity, key market and key players. The study...
  • 世界の肝癌診断検査市場 2019年
    DATA909X10683 / QYResearch / 2019年11月20日 / ※本調査レポートは、肝癌診断検査の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、試薬、計器に、用途別には、病院、身体検査センター、その他にセグメント区分し、肝癌診断検査の世界市場を分析しました。 ・エグゼクティブ・サマリー ・肝癌診断検査の世界市場概要 ・肝癌診断検査の製造コスト構成分析 ・肝癌診断検査の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・肝癌診断検査の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・肝癌診断検査のセグメント分析（種類別） （試薬、計器）...The global Liver Cancer Diagnostic Tests market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Liver Cancer Diagnostic Tests volume and value at global level, regional level and company level. From a global perspective, this report represents overall Liver Cancer Diagnostic Tests market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Liver Cancer Diagnostic Tests in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 乳がん診断および薬物技術の世界市場：規模・現状・予測2019-2025
    DATA909X18241 / QYResearch / 2019年11月25日 / ※当調査レポートでは、乳がん診断および薬物技術の世界市場について調査・分析し、乳がん診断および薬物技術の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（マンモグラフィ、生検、その他）、用途別（乳管がん、浸潤性乳管がん、小葉がん、トリプルネガティブ乳がん）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の乳がん診断および薬物技術市場動向 ・主要企業別マーケットシェア ・乳がん診断および薬物技術の種類別市場規模2014-2019 （マンモグラフィ、生検、その他） ・乳がん診断および薬物技術の用途別市場規模2014-2019 （乳管がん、浸潤性乳管がん、小葉がん、トリプルネガティブ乳がん） ・乳がん診断および薬物技術の北米市場：主要企業・種類別/用途別市場規模 ・乳がん診断および薬物技術のヨーロッパ市場：主要企業・種類別/用途別市場規模...Breast cancer is a malignant tumor that occurs in the epithelial tissue of the breast gland.Breast Cancer Diagnostic and Drug Technologies include mammography, biopsy and so on.In 2018, the global Breast Cancer Diagnostic and Drug Technologies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Breast Cancer Diagnostic and Drug Technologies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Breast Cancer Diagnostic and Drug Technologies development in...
  • 口腔がん診断の世界市場：規模・現状・予測2019-2025
    DATA909X18784 / QYResearch / 2019年11月25日 / ※当調査レポートでは、口腔がん診断の世界市場について調査・分析し、口腔がん診断の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（コンピューター断層撮影（CT）スキャン、磁気共鳴イメージング（MRI）、陽電子放出断層撮影（PET）、超音波検査、生検、X線、内視鏡検査、蛍光イメージング、その他）、用途別（病院＆クリニック、研究機関、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の口腔がん診断市場動向 ・主要企業別マーケットシェア ・口腔がん診断の種類別市場規模2014-2019 （コンピューター断層撮影（CT）スキャン、磁気共鳴イメージング（MRI）、陽電子放出断層撮影（PET）、超音波検査、生検、X線、内視鏡検査、蛍光イメージング、その他） ・口腔がん診断の用途別市場規模2014-2019 （病院＆クリニック、研究機関、その他） ・口腔がん診断の北米市場：主要企業・種類別/用途別市場規模 ・口腔がん診断のヨーロッパ市場：主要企業・種類別/用途別市場規模...Oral Cancer Diagnostic is a doctor who discovers or diagnoses cancer through a series of tests on the mouth.In 2018, the global Oral Cancer Diagnostic market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Oral Cancer Diagnostic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oral Cancer Diagnostic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered...
  • 世界の呼吸器診断装置市場 2019年
    DATA909X14323 / QYResearch / 2019年11月20日 / ※本調査レポートは、呼吸器診断装置の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、固定診断装置、ポータブル診断装置に、用途別には、病院、診療所、身体検査センターにセグメント区分し、呼吸器診断装置の世界市場を分析しました。 ・エグゼクティブ・サマリー ・呼吸器診断装置の世界市場概要 ・呼吸器診断装置の製造コスト構成分析 ・呼吸器診断装置の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・呼吸器診断装置の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・呼吸器診断装置のセグメント分析（種類別） （固定診断装置、ポータブル診断装置）...The global Respiratory Diagnostic Devices market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Respiratory Diagnostic Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Respiratory Diagnostic Devices market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Respiratory Diagnostic Devices in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の耳鼻咽喉科診断及び外科用装置市場 2019年
    DATA909X07362 / QYResearch / 2019年11月15日 / ※本調査レポートは、耳鼻咽喉科診断及び外科用装置の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、診断機器、手術機器に、用途別には、病院、歩行環境、診療所（ENT）にセグメント区分し、耳鼻咽喉科診断及び外科用装置の世界市場を分析しました。 ・エグゼクティブ・サマリー ・耳鼻咽喉科診断及び外科用装置の世界市場概要 ・耳鼻咽喉科診断及び外科用装置の製造コスト構成分析 ・耳鼻咽喉科診断及び外科用装置の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・耳鼻咽喉科診断及び外科用装置の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・耳鼻咽喉科診断及び外科用装置のセグメント分析（種類別） （診断機器、手術機器）...The global ENT Diagnostic and Surgical Devices market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on ENT Diagnostic and Surgical Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall ENT Diagnostic and Surgical Devices market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of ENT Diagnostic and Surgical Devices in North America, Europe, China, Japan, Southeast Asia and...

    • ◆H&Iグローバルリサーチのお客様（例）◆